QBFM
CELG

QS Batterymarch Financial Management’s Celgene Corp CELG Stock Holding History

QS Batterymarch Financial Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16.4M Hold
173,040
– – 0.43% 55
2014
Q2 		$14.9M Sell
173,040
-33,864
-16% -$2.58M 0.38% 68
2014
Q1 		$14.4M Buy
206,904
+14,202
+7% +$1.12M 0.3% 89
2013
Q4 		$16.3M Buy
192,702
+36,730
+24% +$2.91M 0.34% 68
2013
Q3 		$12M Sell
155,972
-74,654
-32% -$5.23M 0.26% 110
2013
Q2 		$13.5M Buy
+230,626
New +$13.9M 0.26% 95

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

QS Batterymarch Financial Management's CELG Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Celgene Corp (CELG) position steady in Q3 2014 at 173,040 shares worth $16.4M. The position accounts for 0.43% of the portfolio, ranked #55.

QS Batterymarch Financial Management first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • QS Batterymarch Financial Management held 173,040 shares of Celgene Corp worth $16.4M as of Q3 2014.
  • QS Batterymarch Financial Management left its Celgene Corp share count unchanged in Q3 2014.
  • Celgene Corp made up 0.43% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #55 holding.
  • QS Batterymarch Financial Management first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.